BCL2 and breast carcinoma: In a study conducted by Sahin et al., it was shown that the risk of chemically-induced breast cancer was decreased in rats in vivo through treatment with a lycopene and genistein combination that ensured a reduction of Bcl-2 and an increase in Bax proteins [24].